TG Forum Logo TG Forum Logo

Assessing the impact of Lp(a) lowering with pelacarsen (YQJ330) on major cardiovascular events in patients with CVD (Lp(a)HORIZON) (NCT04023552)

You are here: Home > Trials

Please login or create a FREE account to view this content

Educational Partners and Supporters

(Founding Partner)

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.